ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Biomarkers - Technologies,markets and companies Published on September 2011
Report Summary This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological responses to a therapeutic intervention. Tests based on biomarkers have been around for more than half a century, but interest in their application for diagnostics and drug discovery as well as development has increased remarkably since the beginning of the 21st century. This report describes different types of biomarkers and their discovery using various '-omics' technologies such as proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker. Currently the most important applications of biomarkers are in drug discovery and development. The role of biomarkers in various therapeutic areas particularly cancer, cardiovascular diseases and disorders of the central nervous system, is described. Biomarkers are useful not only for diagnosis of some of these diseases but also for understanding the pathomechanism as well as a basis for development of therapeutics. Biomarkers will facilitate the combination of therapeutics with diagnostics and will thus play an important role in the development of personalized medicine. Biomarkers play a role in use of pharmacogenetics, pharmacogenomics and pharmacoproteomics for development of personalized medicine. Many of the regulatory issues concerning biomarkers are related to genomics, proteomics, molecular diagnostics and pharmacogenomics/pharmacogenetics. Validation of biomarkers and their role in clinical trials is discussed. Biomarker markets are estimated from 2010 to 2020 according to share of markets for various technologies and applications: proteomics, metabolomics, molecular diagnostics, drug discovery, clinical trials, and bioinformatics. Market values are further split according to therapeutic applications and major geographical areas. Unfulfilled needs in biomarkers are identified as well as the drivers for biomarker markets. Challenges facing the biomarker industry and strategies for developing biomarker markets are discussed. A large number of companies with varying technical backgrounds are involved in biomarkers and 276 of these are profiled in part 2 of the report with classification into various categories.These also include major pharmaceutical companies. There is tabulation of 513 collaborations between companies and additional academic collaborations are mentioned in the individual profiles of companies. The report is supplemented by 1,000 references, 65 tables and 13 figures
Table of Content TABLE OF CONTENTS 0. Executive Summary 21 1. Introduction 23 Definitions 23 Historical aspects of biomarkers 23
Biomarkers - Technologies,markets and companies (From Issuu)
Page 1/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Classification of biomarkers 24 Biological marker as response to therapeutic intervention 25 Pharmacokinetic/pharmacodynamics biomarkers 25 Predictive biomarkers 25 Valid biomarkers 26 Types of biomarkers 26 Genes as biomarkers 26 Proteins as biomarkers 27 Proteomics 27 DNA biomarkers 28 Mitochondrial DNA 28 Mitochondrial mutations 28 RNA biomarkers 28 Transcriptomics 29 MicroRNAs 30 Metabolomics 30 Glycomics 30 Single nucleotide polymorphisms 31 Haplotyping 31 Cell biomarkers of disease 32 Stem cell biomarkers 32 Association of stem cell biomarkers with disease 32 Cancer stem cell biomarkers 33 Endoglin as a functional biomarker of stem cells 33 p75NTR as a biomarker to isolate adipose tissue-derived stem cells 33 Protein expression profile as biomarker of stem cells 33 STEMPRO' EZChek' for analysis of biomarkers of hESCs 34 SSEA-4 as biomarker of MSCs 34 Gaseous mediators as biomarkers of disease 34 Autoantibodies as biomarkers of autoimmune diseases 34 Comparison of various types of biomarkers 35 Biomarkers and systems biology 36 Systems biology approach to biomarker identification 37 Relation of biomarkers to other technologies and healthcare 37 Biomarkers and translational medicine 38 Limitations of use of biomarkers in healthcare 38 2. Technologies for Discovery of Biomarkers 41 Introduction 41 The ideal biomarker 41 Genomic technologies 41 Gene expression 41 Whole genome expression array 42 Gene expression profiling on whole blood samples 43 Profiling gene expression patterns of white blood cells 43 Tissue microarrays for study of biomarkers 43 Epigenomic technologies 44 Discovery of methylation biomarkers 44 Proteomic technologies 45
Biomarkers - Technologies,markets and companies (From Issuu)
Page 2/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! 2D GE 46 Biomarker Amplification Filter 47 CellCarta速 proteomics platform 47 Isotope-coded affinity tags 48 Liquid chromatography-MS/MS 48 Lucid Proteomics System 48 Magnetics beads for protein biomarker discovery 49 MASStermind' 49 Mass spectrometry 49 2D PAGE and mass spectrometry 50 Imaging mass spectrometry 50 MALDI mass spectrometry for biomarker discovery 51 Quantitative tandem MS 52 Single-molecule mass spectrometry using a nanopore 52 Requirements for MS-based proteomic biomarker development 53 Protein tomography 53 Protein biochips/microarrays and biomarkers 53 Antibody-based biomarker discovery 54 Detection of biomarkers using peptide array technology 54 Discovery of biomarkers by MAb microarray profiling 54 Protein nanobiochip 55 Gene expression microarray data as a source of protein biomarkers 55 Quantification of protein biomarkers 55 Mass spectrometry for quantification of protein biomarkers 55 Real-time PCR for quantification of protein biomarkers 56 CyTOF for quantification of biomarkers 56 Search for biomarkers in body fluids 56 Challenges and strategies for discovey of protein biomarkers in plasma 57 3-D structure of CD38 as a biomarker 58 BD' Free Flow Electrophoresis System 58 Isotope tags for relative and absolute quantification 58 Plasma protein microparticles as biomarkers 59 Proteome partitioning 59 Stable isotope tagging methods 60 Technology to measure both the identity and size of the biomarker 60 Targeted proteomic approaches 61 Biomarkers in the urinary proteome 61 Peptides in body fluids and tissues as biomarkers of disease 61 Analysis of peptides in bodily fluids 62 Serum peptidome patterns 62 SISCAPA method for quantitating proteins and peptides in plasma 63 Comparison of proteomic profiling technologies for discovery of biomarkers 63 Verification for interlaboratory reproducibility of protein biomarkers 63 Significance of similar protein biomarkers in different tissues 64 Glycomic technologies 65 Metabolomic technologies 65 Genome-wide association studies for identification of metabolic biomarkers 66 Lipid profiling 66
Biomarkers - Technologies,markets and companies (From Issuu)
Page 3/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Mass spectrometry-based kits for discovery of metabolic biomarkers in plasma 66 Role of metabolomics in biomarker identification and pattern recognition 67 Urinary profiling by capillary electrophoresis 67 Validation of biomarkers in large-scale human metabolomics studies 67 Lipidomics 67 Disease biomarkers in breath 68 Portable breath test for volatile organic compounds 68 Detection of breath biomarkers by sensation technology 69 Detection of breath biomarkers optical frequency comb spectroscopy 69 Detection of breath biomarkers by infrared absorption spectroscopy 69 Fluorescent indicators for biomarkers 70 Molecular imaging technologies 70 Computer tomography 70 Magnetic resonance imaging 71 Positron emission tomography 71 Advantages of imaging biomarkers 72 Monitoring in vivo gene expression by molecular imaging 72 Molecular imaging in vivo as a biomarker 72 Challenges and future prospects of molecular imaging 73 Basic research in molecular imaging 73 Imaging intracellular NADH as a biomarker of disease 73 Devices for molecular imaging 74 Imaging biomarkers in clinical trials 74 Molecular imaging in clinical practice 74 Nuclear magnetic resonance 74 Chemical derivatization to enhance biomarker detection by NMR 75 Fluxomics by using NMR 75 Nanobiotechnology 75 Nanomaterials for biolabeling 76 Quantum dot molecular labels 77 Bioconjugated QDs for multiplexed profiling of biomarkers 77 Magnetic nanotags for multipley detection of biomarkers 78 Nanoproteomics and biomarkers 78 High-field asymmetric waveform ion mobility mass spectrometry 78 Nanoparticles for molecular imaging 78 Nanoparticles for discovering biomarkers 79 Nanosensors for measuring biomarkers in blood 79 Nanobiochip sensor technique for analysis of oral cancer biomarkers 80 Nucleoprotein nanodevices for detection of cancer biomarkers 80 Future prospects of application of nanobiotechnology for biomarkers 80 Bioinformatics 81 Biomarker Workflow Guide 81 Analysis of microarray data for selecting useful biomarkers 81 Role of bioinformatics in discovery of protein biomarkers 82 Role of bioinformatics in detection of cancer biomarkers 82 Biomarker databases 83 Gene networks as biomarkers 83 Role of bioinformatics in integrating various data and biomarker discovery 83
Biomarkers - Technologies,markets and companies (From Issuu)
Page 4/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Evaluation of biomarker studies 84 3. Biomarkers and Molecular Diagnostics 85 Introduction 85 Molecular diagnostic technologies 85 Polymerase chain reaction 85 Amplification 85 Target selection 86 Detection of amplified DNA 86 Limitations of PCR 86 Real-time PCR systems 87 Limitations of real-time PCR 87 Future applications of real-time Q-PCR 88 Combined PCR-ELISA 88 Non-PCR methods 88 Linked Linear Amplification 89 Transcription mediated amplification 89 Rapid analysis of gene expression 89 WAVE nucleic acid fragment analysis system 89 DNA probes with conjugated minor groove binder 90 Rolling circle amplification technology 90 Gene-based diagnostics through RCAT 91 RCAT-immunodiagnostics 91 RCAT-biochips 92 RCAT-pharmacogenomics 92 Circle-to-circle amplification 92 Biochips and microarrays 92 Applications of biochips/microarrays 93 Role of biochip/microarrays in discovery of biomarkers 93 Biomarkers and high throughput molecular screening 94 Detection and expression profiling of miRNA 94 Real-time PCR for expression profiling of miRNAs 95 Real-time PCR for expression profiling of miRNAs 95 Use of LNA to explore miRNA 95 Microarrays for analysis of miRNA gene expression 95 4. Biomarkers for Drug Discovery & Development 97 Introduction 97 Biomarker technologies for drug discovery 98 Proteomics-based biomarkers for drug discovery 98 Chemoproteomics 98 Activity-based chemical proteomics 98 Transcriptomics for drug discovery 99 AvalonRx速 drug discovery platform 99 Metabolomics for drug discovery 99 Biomarkers and drug safety 100 Biomarkers of adverse drug reactions 100 Applications of biomarkers in drug safety studies 101 Genomic technologies for toxicology biomarkers 101 Proteomic technologies for toxicology biomarkers 102
Biomarkers - Technologies,markets and companies (From Issuu)
Page 5/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Metabonomic technologies for toxicology biomarkers 102 Integration of genomic and metabonomic data to develop toxicity biomarkers 102 Toxicology studies based on biomarkers 103 Biomarkers of hepatotoxicity 104 Biomarkers of nephrotoxicity 105 Cardiotoxicity 106 Neurotoxicity 107 Applications of biomarkers for drug development 107 Application of metabonomics/metabolomics for drug development 107 Role of pharmacokinetic/pharmacodynamic biomarkers in drug development 108 Molecular imaging as a biomarker in drug development 109 Molecular imaging in preclinical studies 109 Molecular imaging in clinical trials 110 Prospects of molecular imaging in drug discovery and development 111 Biomarkers in clinical trials 111 NIH recommendations on the use of biomarkers in clinical trials 112 Advantages of biomarkers for drug development 113 Limitations and problems with use of biomarkers in clinical trials 113 Application of biomarkers by the pharmaceutical companies 114 Use of biomarkers in relation to stage of drug discovery and development 115 Drug development in cardiovascular disorders 115 Drug development in neurological disorders 115 Future prospects of biomarker-based drug development 116 The Biomarker Alliance 116 Molecular Libraries and Imaging Roadmap of NIH 117 Biomarkers Consortium 117 Pharmacogenomic biomarker information in drug labels 118 Concluding remarks on the future trends in biomarker development 118 5. Role of Biomarkers in Healthcare 121 Introduction 121 Biomarkers of inflammation 121 ESR and CRP as biomarkers of inflammation 122 Biomarkers of oxidative stress 122 1,4-dihydroxynonane-mercapturic acid 122 Oxidative DNA damage 123 Proteins as biomarkers of oxidative stress in diseases 123 Testing for oxidative stress 123 Biomarkers in metabolic disorders 123 Biomarkers of acute intermittent porphyria 123 Liver X receptors 124 Biomarkers of diabetes mellitus 124 Biomarkers of hyperglycemia 125 Biomarkers of diabetes-associated oxidative stress 125 Biomarkers of inflammation associated with diabetes 126 Biomarkers of renal complications in diabetes mellitus type 2 126 Biomarkers of diabesity 126 Glycosylated hemoglobin in diabetes mellitus 126 Glycated albumin as a biomarker of diabetes mellitus 127
Biomarkers - Technologies,markets and companies (From Issuu)
Page 6/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Lack of C-peptide as biomarker of complications of diabetes type 1 127 Serum retinol binding protein 4 as biomarker of insulin resistance 127 Biomarkers of metabolic syndrome 128 Adiponectin 128 Biomarkers in immune disorders 129 Biomarkers relevant to organ transplantation 129 Biomarkers of graft versus host disease 129 Biomarkers of renal allograft failure 130 Biomarkers of renal transplant tolerance 131 Biomarkers of lung transplant rejection 132 Systemic lupus erythematosus 132 Current management and need for biomarkers 132 Role of collaborative efforts and databases of SLE biomarkers 133 C4d-bearing reticulocytes 133 Adiponectin 133 CB-CAPS 133 Genetic loci of SLE 134 Epigenetic biomarkers of SLE 134 Biomarkers of musculoskeletal disorders 134 Biomarkers of rheumatoid arthritis 134 Circulating cytokines in RA 135 miRNA biomarkers in RA 135 Serum CRP in RA 135 Assays for biomarkers of RA 136 Biomarkers of spondylarthritis 136 Biomarkers of osteoarthritis 137 Biomarkers of osteoporosis 138 Dual x-ray absorptiometry 138 Bone imaging with quantitative CT and MRI 138 Assays for detection of biomarkers of osteoporosis 139 Biomarkers of infectious diseases 139 Application of proteomics for discovering biomarkers of infections 140 Chemokines as biomarkers of infection 140 Circulating CPS-1 as biomarkers of organ damage in sepsis 141 CoQ10 level reduction in septic shock 141 Endotoxin as biomarker of infection 141 Nitric oxide as a biomarker of sepsis 142 Procalcitonin as a guide to antibiotic therapy in infections 142 Soluble urokinase plasminogen activator receptor 143 Systemic inflammatory response syndrome 143 Tuberculosis 144 Conventional diagnosis of tuberculosis 144 Molecular diagnostics for tuberculosis 145 Biomarkers for tuberculosis 145 Biomarkers of pulmonary tuberculosis in the breath 145 Biomarkers of viral infections 146 Viral hepatitis 146 Biomarkers of SARS 148
Biomarkers - Technologies,markets and companies (From Issuu)
Page 7/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Biomarkers of HIV 148 Biomarkers in parasitic infections 149 Role of biomarkers in malaria 149 Identification of biomarkers in Schistosomiasis infections 150 Biomarkers of liver disease 150 Breath biomarkers of liver disease 151 Biomarkers of viral hepatitis B and C 151 Biomarkers of liver injury 152 Biomarkers of liver cirrhosis 152 FibroMax 152 Biomarkers of pancreatitis 153 Biomarkers of renal disease 153 Biomarkers of lupus nephritis 153 Biomarkers of diabetic nephropathy 154 Cystatin C as biomarker of glomerular filtration rate (GFR) 154 Estimated GFR and albuminuria as biomarkers of chronic kidney disease 154 Proteomic biomarkers of acute kidney injury 155 Biomarkers of pulmonary diseases 155 Biomarkers of oxidative stress in lung diseases 156 Biomarkers of survival in acute respiratory distress syndrome 156 Urinary NO as biomarker 156 Plasma biomarkers related to inflammation 156 Pulmonary surfactant proteins as biomarkers for lung diseases 157 Cytokine/chemokine biomarkers of SARS 157 Biomarkers of chronic obstructive pulmonary disease 157 Alpha1-antitrypsin gene polymorphisms predisposing to emphysema 158 BNP as a biomarker of chronic pulmonary disease 158 Chromagranin A (CgA) as biomarker of airway obstruction in smokers 158 Gene expression profile in peripheral blood of patients with COPD 158 Increased expression of PIGF as a biomarker of COPD 159 Biomarkers of asthma 159 Biomarker for rhinovirus-induced asthma exacerbation 159 Biomarkers for predicting response to corticosteroid therapy 159 Comparison of biomarkers of asthma and COPD 160 Cytokines as biomarkers of asthma severity 160 Exaled NO as a biomarker of asthma 160 Endothelin-1 in exhaled breath as biomarker of asthma 161 IgE as guide to dosing of omalizumab for asthma 161 Periostin as a biomarker for treatment of asthma with lebrikizumab 162 Biomarkers for cystic fibrosis 162 Biomarkers of pulmonary embolism 162 D-dimer as biomarker of thromboembolism 162 BNP and cTnT as biomarkers of outcome in pulmonary embolism 163 Biomarkers in gynecology and obstetrics 163 Biomarkers of menopause 163 Biomarkers of premenstrual dysphoric disorder 164 Biomarkers of endometriosis 164 Biomarkers for preeclampsia 165
Biomarkers - Technologies,markets and companies (From Issuu)
Page 8/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Protein biomarker of preeclampsia in urine 165 Protein biomarkers of preeclampsia in CSF 165 Protein HtrA1 as biomarker for preeclampsia 166 sFlt1 and soluble endoglin as biomarkers of preeclampsia 166 RNA biomarkers 167 Biomarkers of premature birth 167 Biomarkers of oxidative stress in complicated pregnancies 168 Fetal biomarkers in maternal blood 168 Biomarkers for genetic disorders 168 Biomarkers for Down's syndrome 168 Biomarkers for muscular dystrophy 169 Biomarkers of phenylketonuria 169 Genetic biomarkers for psoriasis 170 Biomarkers of lysosomal storage disorders 170 Biomarkers of aging 171 Effect of calorie restriction on biomarkers of longevity 173 Genes as biomarkers of aging 173 Mitochondrial mutations as biomarkers of aging 173 Telomere attrition as aging biomarker 173 Gene variants as determinants of biological age 174 Genetic signatures of longevity 174 Low serum thyroid hormone level as biomarker of longevity 174 Role of bioinformatics in search for biomarkers of aging 175 Study of biomarkers of aging in a genetically homogeneous population 175 Biomarkers of miscellaneous disorders 175 Biomarkers of inflammatory bowel disease 175 Biomarkers of erectile dysfunction 176 Biomarkers of fever 177 Biomarkers of heat stroke 177 Biomarkers of radiation injury 177 Biomarkers common to multiple diseases 177 Nasal nitric oxide as a biomarker of response to rhinosinusitis therapy 178 Vitamin D as a biomarker of disease 178 Biomarkers and nutrition 179 Biomarkers in nutritional epidemiology 179 Biomarkers of nutritional status 179 Biomarkers of branched chain amino acid status 179 Biomarkers of caloric restriction 180 Biomarkers of malnutrition 180 Proteomic biomarkers and nutrition 180 Biomarkers of gene-environmental interactions in human disease 181 6. Biomarkers of Cancer 183 Introduction 183 The ideal biomarker for cancer 183 Single vs multiple biomarkers of cancer 184 Types of cancer biomarkers 184 HER3 as biomarker of cancer 185 DNA repair biomarkers 185
Biomarkers - Technologies,markets and companies (From Issuu)
Page 9/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! miRNAs as biomarkers in cancer 185 Circulating miRNAs for cancer detection 187 Diagnostic value of miRNA in cancer 187 Biomarkers of epigenetic gene silencing in cancer 187 Immunologic biomarkers of cancer 188 Molecular diagnostic techniques for cancer 188 Technologies for detection of cancer biomarkers 189 Genomic technologies for cancer biomarkers 189 Cold-PCR 189 Genome analysis at the molecular level 190 Sequencing-based approaches for detection of cancer biomarkers 190 Early detection of tumor suppressor gene mutations 190 Biomarkers of PTEN tumor suppressor gene status 191 HAAH as a biomarker for cancer 191 KRAS as a biomarker of cancer 192 Telomerase as a biomarker of cancer 192 Digital karyotyping for cancer biomarkers 192 LigAmp for detection of gene mutations in cancer 193 Mitochondrial DNA as a cancer biomarker 193 Tissue microarrays for study of cancer biomarkers 193 Molecular fingerprinting of cancer 194 Biomarkers of inflammation in cancer 195 Proteomic technologies for detecting biomarkers of cancer 195 2D PAGE 196 Antibody-based detection of protein biomarkers 196 Aptamer-based molecular probes for cancer biomarker discovery 197 Cancer immunomics to identify autoantibody signatures 197 Desorption electrospray ionization for detection of cancer biomarkers 198 Detection of circulating nucleosomes in serum of cancer patients 198 Detection of tumor markers with ProteinChip technology 198 eTag assay system for cancer biomarkers 199 Glycoprotein biomarkers of cancer 199 HER-2/neu oncoprotein as biomarkers for cancer 200 Humoral proteomics 200 Laser capture microdissection 200 Membrane-type serine protease-1 201 Phage display technology 201 Proteomic analysis of cancer cell mitochondria 201 Proteomic technologies for detection of autoimmune biomarkers 202 SELDI-TOF MS 202 Serum proteome analysis for early detection of cancer 202 Triple-quadrupole MS for detection of mutant proteins 203 Targeted MS for validation of cancer biomarkers in plasma 203 Tissue proteomics for discovery of cancer biomarkers 203 Metabolomic biomarkers of cancer 203 Choline phospholipid biomarkers of cancer 204 Hypoxia-inducible factor-1 204 Detection of drug resistance in cancer by metabolic profiling 205
Biomarkers - Technologies,markets and companies (From Issuu)
Page 10/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Epitomics for the early detection of cancer 205 Detection of biomarkers of DNA methylation 205 PCR with bisulfite for detecting DNA methylation biomarkers in cancer 207 MDScan' microarray technology 208 Rubicon MethylPlex technology 208 Epigenomics Marker Machine for DNA methylation biomarkers 208 Sequenom's integrated genetic analysis platform 209 Histone deacetylase 209 Mucins as epigenetic biomarkers in epithelial cancers 209 Nanobiotechnology for early detection of cancer to improve treatment 210 Selective expression of biomarkers by cancer compared with normal tissues 210 Ultrasound radiation to enhance release of a tumor biomarker 210 In vivo imaging of cancer biomarkers 211 Computer tomography 211 Optical systems for in vivo molecular imaging of cancer 211 Positron emission tomography 211 Imaging of tumor oxygenation and microvascular permeability by MRI 212 Xenon-enhanced MRI 212 Kallikrein gene family and cancer biomarkers 212 Circulating cancer cells in blood as biomarkers of cancer 213 Applications of cancer biomarkers 214 Use of biomarkers for cancer classification 214 Cancer classification using microarrays 214 Proteomic classification of cancer 214 Use of biomarkers for early detection of cancer 214 Applications of biomarkers for cancer diagnosis 215 Methylated DNA sequences as cancer biomarkers 215 MicroRNA expression profiling for diagnosis of human cancers 216 MUC4 as a diagnostic biomarker in cancer 216 Applications of biomarkers for cancer diagnosis and therapy 216 Asparagine synthetase as biomarker for therapy with L-asparaginase 217 Peptide-based agents for targeting cancer biomarkers 217 Biomarkers for assessing efficacy of cancer therapy 218 ERCC1-XPF expression as a biomarker of response to chemotherapy 218 P53 expression level as biomarker of efficacy of cancer gene therapy 218 Biomarkers of angiogenesis for developing antiangiogenic therapy 218 Biomarkers of response to antiangiogenic agents 219 Circulating endothelial cells as targets for antiangiogenic drugs 219 Imaging biomarkers for evaluation of antiangiogenic agents 219 Tumor endothelial markers 220 VEGF signaling inhibitors as biomarkers 220 VEGF-PET imaging for analysis of angiogenic changes within a tumor 221 Biomarkers of prognosis in cancer treatment 221 Biomarkers of drug resistance in cancer 221 A systems approach to biomarkers of innate drug resistance 222 Epithelial membrane protein-1 as a biomarker of gefitinib resistance 222 Methylation biomarkers of drug resistance in cancer 222 STAT3 and resistance to cisplatin 223
Biomarkers - Technologies,markets and companies (From Issuu)
Page 11/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Biomarkers of radiation therapy for cancer 223 Role of biomarkers in drug development in oncology 223 Molecular imaging of tumor as a guide to drug development 224 Use of PET to assess response to anticancer drugs 225 Use of MRI to assess response to anticancer drugs 225 Biomarkers in plucked hair for assessing cancer therapy 225 Molecular targets of anticancer drugs as biomarkers 226 Safety biomarkers in oncology studies 226 Role of biomarkers in phase I clinical trials of anticancer drugs 226 Biomarkers according to location/type of cancer 227 Bladder cancer biomarkers 227 Detection of FGFR3 mutations in urine for diagnosis of bladder cancer 227 NMP22 BladderChek 227 Urinary telomerase as biomarker for detection of bladder cancer 228 Concluding remarks abut biomarkers of urinary cancer 228 Brain tumor biomarkers 228 14-3-3zeta positive expression as a prognostic biomarker for GBM 229 Biomarkers to predict response to EGFR inhibitors 229 CD133 as biomarker of resistance to radiotherapy 229 Circulating microvesicles as biomarkers 230 CSF protein profiling 230 CSF attractin as a biomarker of malignant astrocytoma 230 Methylation profiling of brain tumors 230 Metabolite biomarkers of brain tumors 231 miRNAs as biomarkers of brain tumors 232 MRI biomarker for response of brain tumor to therapy 232 Multigene predictor of outcome in GBM 232 Neuroimaging biomarkers combined with DNA microarray analysis 233 Receptor protein tyrosine phosphatase ' as biomarker of gliomas 233 Serum protein fingerprinting 233 VEGF-R2 as biomarker of angiogenesis in brain tumors 234 Bone tumor biomarkers 234 Cytogenetics for the study of bone and soft tissue tumors 234 Biomarkers of Ewing's tumors 234 Role of biomarkers in the diagnosis of bone tumors 235 Breast cancer biomarkers 235 Biomarkers of breast cancer in breath 236 Biomarkers for breast cancer in nipple aspiration fluid 236 Circulating nucleic acid biomarkers of breast cancer 236 Flow cytometry for quantification of biomarker expression patterns 237 Plasma proteomics for biomarkers of breast cancer 237 Quantitative realtime PCR assays for biomarker validation 237 Cdk6 as a biomarker of breast cancer 238 Centromere protein-F 238 Carbonic anhydrase IX 239 COX-2 as a biomarker of breast cancer 239 Glycomic biomarkers of breast cancer 239 HER-2/neu oncoprotein 240
Biomarkers - Technologies,markets and companies (From Issuu)
Page 12/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! High mobility group protein A2 241 Hypermethylated genes as biomarkers of metastatic breast cancer 241 Lipocalin 2 as biomarker of breast cancer progression 242 Long intervening non-coding RNAs 242 Mammaglobin 242 miRNA biomarkers of breast cancer 242 p27 expression as biomarker for survival after chemotherapy 243 Podocalyxin 244 Progranulin as a biomarker of breast cancer 244 Proliferating cell nuclear antigen 244 Protein kinase C as a predictive biomarker of metastatic breast cancer 244 Retinoblastoma tumor suppressor gene as a biomarker 245 Riboflavin carrier protein 245 Risk of invasive cancer after diagnosis of ductal carcinoma in situ 246 Serum CA 15-3 as biomarker of prognosis in advanced breast cancer 246 Suppressor of deltex protein 246 Tumor microenvironment as biomarker of metastasis in breast cancer 246 Type III TGF-' receptor as regulator of cancer progression 247 Diagnostic tests based on breast cancer genes 247 Prognostic role of breast cancer genes 248 Protein biomarkers for breast cancer prevention 249 Biomarkers to evaluate efficacy of chemoprevention 250 Biomarkers of response to chemotherapy of breast cancer 250 Concluding remarks and future prospects of breast cancer biomarkers 251 Cervical cancer biomarkers 251 Gastrointestinal cancer biomarkers 252 Esophageal cancer biomarkers 252 Gastric cancer biomarkers 253 Colorectal cancer biomarkers 253 Head and neck cancer 258 Leukemia biomarkers 259 Chromosome translocations in leukemias 259 DNA methylation biomarkers in leukemia 260 Gene mutations as biomarkers in leukemia 260 Molecular diagnostic techniques for leukemia 261 Proteomic technologies for discovering biomarkers of leukemia 261 Biomarkers of chronic lymphocytic leukemia 262 Biomarkers of chronic myeloid leukemia 262 Biomarkers of drug resistance in leukemia 263 Biomarkers of myelodysplasitic syndromes 263 Lymphoma biomarkers 263 Liver cancer biomarkers 264 Lung cancer biomarkers 264 Autoantibodies as biomarkers in lung cancer 266 Biomarkers associated with neuroendocrine differentiation in NSCLC 266 Biomarkers of chronic inflammation in lung cancer 266 Biomarkers for predicting sensitivity to chemotherapy in lung cancer 267 Biomarkers for prediction of sensitivity to EGFR inhibitors 267
Biomarkers - Technologies,markets and companies (From Issuu)
Page 13/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Circulating tumor cells as biomarkers 268 Gene expression profiling for biomarkers of lung cancer 269 Methylation biomarkers of lung cancer 269 miRNA biomarkers in lung cancer 270 Proteomic biomarkers in exaled breath condensate 270 Serum protein biomarkers of lung cancer 271 tNOX as biomarker of lung cancer 271 Tumor-derived DNA and RNA markers in blood 271 Volatile organic compounds in the exhaled breath 272 Malignant pleural mesothelioma 272 Melanoma biomarkers 272 Nasopharyngeal carcinoma biomarkers 274 Proteomic biomarkers of nasopharyngeal cancer 275 miRNA biomarkers of nasopharyngeal carcinoma 275 Oral cancer biomarkers 276 Ovarian cancer biomarkers 276 Epitomics approach for ovarian cancer biomarkers in serum 277 Gene expression studies in ovarian cancer 278 HE4 protein in urine as a biomarker for ovarian cancer 278 HtrA1 as a biomarker of response to chemotherapy in ovarian cancer 279 Mutation of genes in ovarian cancer 279 Serum biomarkers of ovarian cancer prognosis 279 Serum albumin-associated peptides and proteins 280 Multiplex assays for biomarkers of ovarian cancer 280 Concluding remarks on biomarker-based tests of ovarian cancer 281 Pancreatic cancer biomarkers 281 Discovery and validation of pancreatic cancer biomarkers 282 Cancer stem cells as biomarkers of pancreatic cancer 282 Histone modifications used as biomarkers in pancreatic cancer 283 miRNA biomarkers of pancreatic cancer 283 Proteomic biomarkers of pancreatic cancer 284 Prostate cancer 285 Adipose tissue-derived biomarkers of obesity-related prostate cancer 286 B7-H3 as biomarker of prostate cancer 286 Cancer genetics-guided biomarker signatures of prostate cancer 286 Detection of prostate cancer biomarkers in urine 287 Detection of prostatic intraepithelial neoplasia 288 Epigenetic biomarkers of prostate cancer 288 Gene expression analysis of prostate cancer 289 Genetic biomarkers of prostate cancer 289 Huntingtin Interacting Protein 1 overexpression in prostate cancer 289 Id proteins expression in prostate cancer 290 Identification of prostate cancer mRNA biomarkers 290 Integrative genomic and proteomic profiling of prostate cancer 290 LCM for diagnosis of prostate cancer 290 Loss of p27 as predictor of recurrence of prostate cancer 291 Microarray for diagnosis of prostate cancer 291 miRNA biomarkers of prostate cancer 292
Biomarkers - Technologies,markets and companies (From Issuu)
Page 14/17
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Prostate cancer biomarkers in semen 292 PSA as biomarker of prostate cancer 292 ProPSA as biomarker of prostate cancer 293 Prostate Health Index 293 Prostasomes in blood as biomarker of prostate cancer 293 PSMA as biomarker of prostate cancer 294 Sarcosine as a metabolic biomarker of prostate cancer 294 Serum HAAH as biomarker of prostate cancer 294 Silenced CDH13 gene as a biomarker of cancer 294 Serum-protein fingerprinting 295 Tests for prostate cancer based on genetic dislocations 295 Concluding remarks on biomarkers of prostate cancer 295 Renal cancer biomarkers 296 Gene expression profile of RCC for biomarkers 296 miRNA biomarkers of renal cancer 296 Use of proteomics for detection of RCC biomarkers 296 Use of RCC biomarkers for prognosis and therapy 297 Thyroid cancer biomarkers 298 Detection of BRAF mutation 298 Gene expression biomarkers of thyroid cancer 298 Multiple endocr
Biomarkers - Technologies,markets and companies (From Issuu)
Page 15/17
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Biomarkers - Technologies,markets and companies
Product Formats Please select the product formats and the quantity you require.
Digital Copy--USD 5 000.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Biomarkers - Technologies,markets and companies (From Issuu)
Page 16/17
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Biomarkers - Technologies,markets and companies (From Issuu)
Page 17/17